← All trials
NCT00950430
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2008
- Primary completion
- Apr 1, 2018
- Completion date
- Apr 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 2500
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Mayo ClinicLead sponsor
- Mayo ClinicOverall official - principal investigator
- National Institute on Aging (NIA)Collaborator
- Mayo ClinicReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.